Surfactant therapy for acute respiratory failure in children: a systematic review and meta-analysis
2007

Surfactant Therapy for Acute Respiratory Failure in Children

Sample size: 314 publication Evidence: moderate

Author Information

Author(s): Duffett Mark, Choong Karen, Ng Vivian, Randolph Adrienne, Cook Deborah J

Primary Institution: McMaster Children's Hospital

Hypothesis

What is the effect of exogenous pulmonary surfactant on all-cause mortality in children mechanically ventilated for acute respiratory failure?

Conclusion

Surfactant use decreased mortality, was associated with more ventilator-free days and reduced the duration of ventilation.

Supporting Evidence

  • Surfactant use reduced mortality (relative risk = 0.7).
  • Surfactant was associated with increased ventilator-free days (weighted mean difference = 2.5 days).
  • Surfactant reduced the duration of ventilation (weighted mean difference = 2.3 days).
  • No serious adverse events were reported.

Takeaway

Surfactant helps sick kids breathe better and live longer when they have serious lung problems.

Methodology

Systematic review and meta-analysis of randomized controlled trials of surfactant therapy in mechanically ventilated children.

Potential Biases

Potential bias due to lack of blinding in some trials and differences in patient characteristics.

Limitations

Most trials enrolled small numbers of children, and further well-designed multicentre trials are needed.

Participant Demographics

Children with acute respiratory failure, including those with bronchiolitis and ARDS.

Statistical Information

P-Value

0.04

Confidence Interval

0.4 to 0.97

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/cc5944

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication